|
Volumn 173, Issue 4, 2016, Pages 429-431
|
Letters to the Editor
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DELTA OPIATE RECEPTOR;
DOPAMINE 2 RECEPTOR;
FORKHEAD TRANSCRIPTION FACTOR;
FORKHEAD TRANSCRIPTION FACTOR A2;
KAPPA OPIATE RECEPTOR;
LIM PROTEIN;
MU OPIATE RECEPTOR;
NUCLEAR RECEPTOR RELATED FACTOR 1;
UNCLASSIFIED DRUG;
VESICULAR MONOAMINE TRANSPORTER 2;
DRD2 PROTEIN, HUMAN;
MESSENGER RNA;
ALCOHOLISM;
CELL DIFFERENTIATION;
DOPAMINERGIC NERVE CELL;
ENZYME ACTIVATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LETTER;
NONHUMAN;
OPIATE ADDICTION;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN SYNTHESIS;
CASE CONTROL STUDY;
CYTOLOGY;
GENETICS;
INDUCED PLURIPOTENT STEM CELL;
METABOLISM;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
CASE-CONTROL STUDIES;
DOPAMINERGIC NEURONS;
HUMANS;
INDUCED PLURIPOTENT STEM CELLS;
OPIOID-RELATED DISORDERS;
RECEPTORS, DOPAMINE D2;
RECEPTORS, OPIOID, MU;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
|
EID: 84962577867
PISSN: 0002953X
EISSN: 15357228
Source Type: Journal
DOI: 10.1176/appi.ajp.2015.15121545 Document Type: Letter |
Times cited : (5)
|
References (6)
|